Discover
ORIC
ORIC Pharmaceuticals, Inc.
10.83
1 x 10.65
1 x 10.95
bid
ask
+
0.41
3.93%
20 @ 04:00 PM
10.72 -0.11 (1.02%)
| Ytd | 32.40% | |
| 1y | -2.87% |
10.37
day range
11.04
7.23
52 week range
14.93
| Open | 10.48 | Prev Close | 10.42 | Low | 10.37 | High | 11.04 | Mkt Cap | 1.12B |
| Vol | 1.30M | Avg Vol | 1.61M | EPS | -1.44 | P/E | -7.52 | Forward P/E | -6.76 |
| Beta | 1.02 | Short Ratio | 11.29 | Inst. Own | 113.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 9.18 | 200-d Avg | 10.66 | 1yr Est | 20.29 |
| Income Statement | |||
| Operating Expenses | 39.62M | ||
| Research and Development Expense | 31.44M | ||
| Selling, General and Administrative Expense | 8.18M | ||
| Operating Income | -39.62M | ||
| Net Income | -35.77M | ||
| Net Income Common Stock | -35.77M | ||
| Net Income Common Stock (USD) | -35.77M | ||
| Consolidated Income | -35.77M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -35.77M | ||
| Earning Before Interest & Taxes (USD) | -35.77M | ||
| Weighted Average Shares | 105.47M | ||
| Weighted Average Shares Diluted | 105.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.40M | ||
| Cash and Equivalents (USD) | 56.40M | ||
| Investments | 363.32M | ||
| Investments Current | 225.54M | ||
| Investments Non-Current | 137.78M | ||
| Current Assets | 290.23M | ||
| Property, Plant & Equipment Net | 2.15M | ||
| Total Assets | 436.76M | ||
| Current Liabilities | 17.77M | ||
| Total Liabilities | 21.21M | ||
| Accumulated Retained Earnings (Deficit) | -728.01M | ||
| Accumulated Other Comprehensive Income | -290.00K | ||
| Shareholders Equity | 415.56M | ||
| Shareholders Equity (USD) | 415.56M | ||
| Assets Non-Current | 146.53M | ||
| Liabilities Non-Current | 3.43M | ||
| Trade and Non-Trade Payables | 2.90M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 270.00K | ||
| Net Cash Flow from Financing | 61.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.73M | ||
| Capital Expenditure | -2.00K | ||
| Issuance (Purchase) of Equity Shares | 62.13M | ||
| Net Cash Flow from Investing | -17.98M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -17.97M | ||
| Net Cash Flow from Operations | -32.44M | ||
| Share Based Compensation | 6.90M | ||